New Delhi [India], October 4: Leucine Rich Bio Pvt. Ltd., South Asia’s pioneering microbiome company, today unveiled the region’s first-ever Skin Microbiome Test- BugSpeaks facial skin microbiome test. This groundbreaking innovation promises to transform skincare and wellness by providing personalized, science-driven insights based on the unique ecosystem of microbes living onContinue Reading

Ahmedabad (Gujarat) [India], October 3: An ACL tear can feel devastating — but it doesn’t have to be the end of your activity or sports career. With the right care and expert guidance, we help turn this challenge into a powerful comeback. Injury Anterior Cruciate Ligament (ACL) is the KneeContinue Reading

Mumbai (Maharashtra) [India], September 27: Elixir Wellness, the luxury medical wellness brand founded by public health expert and entrepreneur Tanya Khubchandani, has been awarded the prestigious title of Healthcare Startup of the Year at the Entrepreneur India 2025 Awards. Considered one of the country’s most respected platforms for entrepreneurial excellence,Continue Reading

Lucknow (Uttar Pradesh) [India], October 1: Dr. Sankalp Jain, a Lucknow-based medical expert and certified sexologist, is leading a clinically validated, technology-driven approach to improve access and awareness around intimate wellness in India. Adopting FDA-approved innovations and grassroots outreach, his initiative aims to provide safe, effective solutions for issues likeContinue Reading

Ghaziabad (Uttar Pradesh) [India], September 27: The present era is a combination of health and aesthetics, which Simpladent Clinics further promotes in the domain of dentistry innovation. The dental clinic is acknowledged for its ultra-modern implant technology, dedication to patient care and experience. Simpladent Clinics is trusted by many patientsContinue Reading

Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar Hyderabad (Telangana) [India], September 25: Hetero Healthcare Limited, in strategic collaboration with Enzene Biosciences, has launched Perzea, India’s most affordable Pertuzumab biosimilar. The introduction of this targeted therapy for HER2-positive breast cancer demonstrates the synergy between two healthcare leaders committed to advancedContinue Reading